Percutaneous coronary interventions (PCI) are the mainstay for treatment of advanced coronary disease. A majority of PCI involve deployment of a stent in the affected vascular segment. This chapter introduces the concept of using stents as a platform for delivering gene therapies to the vasculature with the overarching aim of mitigating in-stent restenosis (ISR), late stent thrombosis (LST), and neoatherosclerosis (NA), a triad of delayed complications that reduce the overall success rate of PCI. The chapter provides a detailed methodology for coatless reversible attachment of adenoviral (Ad) and adeno-associated viral (AAV) vectors to the metal stent struts along with representative in vitro and in vivo results.
Keywords: Adeno-associated virus; Adenovirus; Fluorescent microscopy; Gene therapy; Green fluorescent protein; In-stent restenosis; Luciferase; Stents; Substrate-mediated gene transfer.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.